In the gastrointestinal tract, COX-1-derived prostaglandins function to increase production of the thick mucus/bicarbonate layer that coats gastric surfaces and buffers them against stomach acid (Vonkeman 2010)
While the current data does not allow to conclude a specific efficacy in the prodrome by a NAC-based early intervention nor its capacity to halt disease progression, it suggests that clinical trials in at-risk individuals are warranted ( Statements Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation
of Colo
Cancers 16 , 3224 (2024)
When administered at a medical clinic rather than a spa, with appropriate screening, the risk profile is low
Wegovy (semaglutide injection) is FDA-approved for: Chronic weight management in adults with a BMI of 30+ (obesity), or BMI of 27+ with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol) Weight management in adolescents aged 12 and older with obesity (initial body weight 60 kg) Reducing cardiovascular risk lowering the risk of heart attack, stroke, or cardiovascular death in adults with established cardiovascular disease who are also overweight or have obesity Wegovy is meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone treatment